Colorectal cancer - capecitabine and tegafur uracil (TA61)
Fast, easy summary view of NICE guidance on 'colorectal cancer'
NICE has recommended that capecitabine or tegafur with uracil (and folinic acid), to be taken by mouth, should be among the first options considered for a person with metastatic colorectal cancer. The choice about which medicine to take should be made jointly by the patient and his or her doctor, and the patient should be informed about the options and the differences between the medicines so that he or she can be fully involved in the decision.
NICE also noted that the use of capecitabine and tegafur with uracil should be overseen by doctors specialising in the use of medicines for colorectal cancer.
In April 2006, following consultation, the Institute decided to make this guidance 'static.' This means that the guidance remains in force and has no scheduled review date. See the review decision, under 'Background information', for further details.
- TA61 Colorectal cancer - capecitabine and tegafur uracil: guidance (web format)
- TA61 Colorectal cancer - capecitabine and tegafur uracil: summary
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: colorectal cancer
- Colorectal cancer - capecitabine and tegafur uracil: review decision - June 2011
- Colorectal cancer - capecitabine and tegafur uracil: review proposal - April 2011
- Review decision
- Review proposal
- Media Briefing - Capecitabine and tegafur with uracil for advanced colorectal cancer
- NICE extends range of advice for people with cancer
- Assessment Report: A review of the evidence for the clinical and cost effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer
This page was last updated: 02 August 2012
- Web format
- Full Guidance (PDF)
- TA61 Defnyddio capecitabine a thegafur gydag uracil ar gyfer canser colorefrol metastatig: deall canllawiau NICE
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.